Notch signaling contributes to proliferation and tumor formation of human T-cell leukemia virus type 1 - Associated adult T-cell leukemia

Proceedings of the National Academy of Sciences of the United States of America

Volumn 107, Issue 38, 2010, Pages 16619-16624

  Pancewicza, Joanna ^a   Taylora, John M ^a   Dattaa, Abhik ^a   Baydouna, Hicham H ^a   Waldmann, Thomas A ^b   Herminec, Olivier ^c   Nicota, Christophe ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA SECRETASE INHIBITOR; GLUTAMIC ACID; NOTCH RECEPTOR; PROLINE; SERINE; THREONINE; CELL CYCLE PROTEIN; ENZYME INHIBITOR; F BOX PROTEIN; FBXW7 PROTEIN, HUMAN; NOTCH1 PROTEIN, HUMAN; NOTCH1 RECEPTOR; SECRETASE; UBIQUITIN PROTEIN LIGASE;

ARTICLE; CARCINOGENESIS; CELL PROLIFERATION; DNA POLYMORPHISM; FRAMESHIFT MUTATION; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; PHENOTYPE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T CELL LEUKEMIA; ADULT; ANIMAL; ANTAGONISTS AND INHIBITORS; CANCER TRANSPLANTATION; CHEMISTRY; DRUG EFFECTS; GENETICS; LEUKEMIA-LYMPHOMA, ADULT T-CELL; METABOLISM; MOUSE; MUTATION; NUCLEOTIDE SEQUENCE; PATHOLOGY; PROTEIN STABILITY; PROTEIN TERTIARY STRUCTURE; XENOGRAFT;

HUMAN T-LYMPHOTROPIC VIRUS 1; MUS;

ADULT; AMYLOID PRECURSOR PROTEIN SECRETASES; ANIMALS; CELL CYCLE PROTEINS; CELL PROLIFERATION; DNA MUTATIONAL ANALYSIS; ENZYME INHIBITORS; F-BOX PROTEINS; HUMANS; LEUKEMIA-LYMPHOMA, ADULT T-CELL; MICE; MUTATION; NEOPLASM TRANSPLANTATION; PROTEIN STABILITY; PROTEIN STRUCTURE, TERTIARY; RECEPTOR, NOTCH1; SIGNAL TRANSDUCTION; TRANSPLANTATION, HETEROLOGOUS; UBIQUITIN-PROTEIN LIGASES;

EID: 78049257314     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1010722107     Document Type: Article

References (31)

1. D'Souza B, Miyamoto A, Weinmaster G (2008) The many facets of Notch ligands. Oncogene 27:5148-5167.
2. Artavanis-Tsakonas S, Rand MD, Lake RJ (1999) Notch signaling: Cell fate control and signal integration in development. Science 284:770-776.
3. Jarriault S, et al. (1995) Signalling downstream of activated mammalian Notch. Nature 377:355-358.
4. Aifantis I, Raetz E, Buonamici S (2008) Molecular pathogenesis of T-cell leukaemia and lymphoma. Nat Rev Immunol 8:380-390.
5. Grabher C, von Boehmer H, Look AT (2006) Notch 1 activation in the molecular pathogenesis of T-cell acute lymphoblastic leukaemia. Nat Rev Cancer 6:347-359.
6. Gupta-Rossi N, et al. (2001) Functional interaction between SEL-10, an F-box protein, and the nuclear form of activated Notch1 receptor. J Biol Chem 276:34371-34378.
7. Minella AC, Clurman BE (2005) Mechanisms of tumor suppression by the SCF(Fbw7). Cell Cycle 4:1356-1359.
8. Weng AP, et al. (2004) Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science 306:269-271.
9. Poiesz BJ, et al. (1980) Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci USA 77:7415-7419.
10. Yoshida M, Seiki M, Yamaguchi K, Takatsuki K (1984) Monoclonal integration of human T-cell leukemia provirus in all primary tumors of adult T-cell leukemia suggests causative role of human T-cell leukemia virus in the disease. Proc Natl Acad Sci USA 81:2534-2537.
11. Migone TS, et al. (1995) Constitutively activated Jak-STAT pathway in T cells transformed with HTLV-I. Science 269:79-81.
12. Curry CL, et al. (2005) Gamma secretase inhibitor blocks Notch activation and induces apoptosis in Kaposi's sarcoma tumor cells. Oncogene 24:6333-6344.
13. Welcker M, Clurman BE (2008) FBW7 ubiquitin ligase: A tumour suppressor at the crossroads of cell division, growth and differentiation. Nat Rev Cancer 8:83-93.
14. O'Neil J, Look AT (2007) Mechanisms of transcription factor deregulation in lymphoid cell transformation. Oncogene 26:6838-6849.
15. Sanchez-Irizarry C, et al. (2004) Notch subunit heterodimerization and prevention of ligand-independent proteolytic activation depend, respectively, on a novel domain and the LNR repeats. Mol Cell Biol 24:9265-9273.
16. O'Neil J, et al. (2007) FBW7 mutations in leukemic cells mediate NOTCH pathway activation and resistance to gamma-secretase inhibitors. J Exp Med 204:1813-1824.
17. Fuchs SY (2002) The role of ubiquitin-proteasome pathway in oncogenic signaling. Cancer Biol Ther 1:337-341.
18. Maillard I, et al. (2004) Mastermind critically regulates Notch-mediated lymphoid cell fate decisions. Blood 104:1696-1702.
19. Wu L, et al. (2000) MAML1, a human homologue of Drosophila mastermind, is a transcriptional co-activator for NOTCH receptors. Nat Genet 26:484-489.
20. Palomero T, et al. (2007) Mutational loss of PTEN induces resistance to NOTCH1 inhibition in T-cell leukemia. Nat Med 13:1203-1210.
21. Maeda M, et al. (1985) Origin of human T-lymphotrophic virus I-positive T cell lines in adult T cell leukemia. Analysis of T cell receptor gene rearrangement. J Exp Med 162:2169-2174.
22. Chiang MY, et al. (2008) Leukemia-associated NOTCH1 alleles are weak tumor initiators but accelerate K-ras-initiated leukemia. J Clin Invest 118:3181-3194.
23. Cullion K, et al. (2009) Targeting the Notch1 and mTOR pathways in a mouse T-ALL model. Blood 113:6172-6181.
24. Takajo I, et al. (2007) Engraftment of peripheral blood mononuclear cells from human T-lymphotropic virus type 1 carriers in NOD/SCID/gammac(null) (NOG) mice. Int J Cancer 121:2205-2211.
25. Real PJ, et al. (2009) Gamma-secretase inhibitors reverse glucocorticoid resistance in T cell acute lymphoblastic leukemia. Nat Med 15:50-58.
26. Chan SM, Weng AP, Tibshirani R, Aster JC, Utz PJ (2007) Notch signals positively regulate activity of the mTOR pathway in T-cell acute lymphoblastic leukemia. Blood 110:278-286.
27. Nefedova Y, Sullivan DM, Bolick SC, Dalton WS, Gabrilovich DI (2008) Inhibition of Notch signaling induces apoptosis of myeloma cells and enhances sensitivity to chemotherapy. Blood 111:2220-2229.
28. Tsukasaki K, et al. (2009) Definition, prognostic factors, treatment, and response criteria of adult T-cell leukemia-lymphoma: A proposal from an international consensus meeting. J Clin Oncol 27:453-459.
29. Breit S, et al. (2006) Activating NOTCH1 mutations predict favorable early treatment response and long-term outcome in childhood precursor T-cell lymphoblastic leukemia. Blood 108:1151-1157.
30. Zhu YM, et al. (2006) NOTCH1 mutations in T-cell acute lymphoblastic leukemia: Prognostic significance and implication in multifactorial leukemogenesis. Clin Cancer Res 12:3043-3049.
31. Nicot C, et al. (2004) HTLV-1-encoded p30II is a post-transcriptional negative regulator of viral replication. Nat Med 10:197-201.